OTC Medical Device Bottleneck Will Have 'Serious Implications' For German Industry, Says BAH’s Dr Cranz
Executive Summary
In an exclusive interview with HBW Insight, the German Medicines Manufacturers´ Association’s (BAH’s) new director general Dr Hubertus Cranz warns of a potentially costly bottleneck forming as German manufacturers scramble to re-certify their self-care medical devices before the May 2020 European Union's new Medical Device Regulations deadline. Dr Cranz also explains how BAH is supporting the country's community pharmacists to help German consumers to self-care safely and responsibly.